Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
about
Transformative tools for tackling tuberculosisDynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature ReviewTuberculosis vaccines: barriers and prospects on the quest for a transformative toolBig brains, meat, tuberculosis, and the nicotinamide switches: co-evolutionary relationships with modern repercussions?Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesThe Mycobacterium tuberculosis Rv2745c plays an important role in responding to redox stress.Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsRecombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyTuberculosis and Healthcare Workers in Underresourced Settings.BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.Current status of new tuberculosis vaccine in children.Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?The potential of the microbiota to influence vaccine responses.Pattern of cytokine and chemokine production by THP-1 derived macrophages in response to live or heat-killed Mycobacterium bovis bacillus Calmette-Guérin Moreau strainWhat Have We Learnt about BCG Vaccination in the Last 20 Years?CD14-159C/T polymorphism in the development of delayed skin hypersensitivity to tuberculin.Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
P2860
Q26784084-796F6FDB-3A7D-4C13-B1F1-C65A417D4CE3Q28072167-21E00D15-53ED-4E9E-8329-E6FD46A8D21DQ28390218-96BF5D30-0748-424E-B424-EF63E308795AQ28661643-CEB0FB40-14A5-4AC2-89A9-26DF7C162B67Q31154267-4514BEF1-D526-4285-B0E4-FF6F5BC5E468Q33893983-B0ACF5C2-E2BF-4E53-9E78-126DBD04192DQ34122572-2B9E159D-AC5A-4020-A878-08F3A1328829Q34441930-572279E9-B2EC-46A8-B030-4E4EC513659EQ35140367-8712D9F7-FB1E-401E-83AE-E9F55BF17330Q35773904-28D9DA4C-4D3E-43C8-B879-E6D7D28671BDQ35782951-BDAE6B1E-7A13-4200-ABC2-DDD36B579F9DQ36219941-C9BC218A-4E5A-479D-903A-A94E39711506Q36838285-0D7AC55A-A190-40FD-8286-9D6DD14D89A0Q36838289-317D841B-EEAF-40FE-9BE5-3BFEBBC7A958Q37130796-826EB394-CC31-4FBF-A5E8-F205F02B9B55Q37473293-F302090E-D35E-462D-9315-4D4A7D5F3917Q38252979-D46F7DD8-3D3E-43FB-9537-4827CD5298B0Q38634154-2ECF75C9-363C-4A10-ACBA-D1FB5ADFB570Q38823603-F2F77D8A-29AE-4B1F-8057-30C143C615DFQ41684091-82CD6F15-DB30-416C-BBEE-310B3F8FBDFCQ47187631-A5B48E6D-6C59-4F65-9BBC-C8D2F1C3CC45Q52338712-6714E5BC-9B50-4C2D-8FA2-FE16AD408C90Q55617820-2C858FBD-A5EB-46BE-AA6D-5543827A5865Q58549133-B311CA56-913B-473C-BB3A-C6F56A77C237
P2860
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Making wider use of the world' ...... in revaccination reconsidered.
@en
type
label
Making wider use of the world' ...... in revaccination reconsidered.
@en
prefLabel
Making wider use of the world' ...... in revaccination reconsidered.
@en
P2860
P356
P1476
Making wider use of the world' ...... in revaccination reconsidered.
@en
P2860
P304
P356
10.1098/RSIF.2013.0365
P577
2013-07-31T00:00:00Z